Parkman Healthcare Partners’s Annexon ANNX Stock Holding History

Parkman Healthcare Partners’s Portfolio ANNX Stock Details ANNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66M	Sell	641,029 -32,984	-5%	-$182K	0.37%	62
2026 Q1	$3.73M	Buy	674,013 +72,811	+12%	+$410K	0.39%	70
2025 Q4	$3.02M	Buy	601,202 +195,249	+48%	+$746K	0.29%	80
2025 Q3	$1.24M	Buy	405,953 +1,759	+0.4%	+$4.37K	0.13%	84
2025 Q2	$970K	Buy	404,194 +52,758	+15%	+$106K	0.11%	84
2025 Q1	$678K	Buy	351,436 +20,587	+6%	+$68.5K	0.08%	87
2024 Q4	$1.7M	Buy	330,849 +2,236	+0.7%	+$13.8K	0.23%	78
2024 Q3	$1.95M	Buy	328,613 +1,768	+0.5%	+$10.5K	0.25%	75
2024 Q2	$1.6M	Sell	326,845 -19,842	-6%	-$103K	0.21%	77
2024 Q1	$2.49M	Buy	+346,687	New	+$1.8M	0.31%	79

Other funds holding ANNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Parkman Healthcare Partners's ANNX Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Annexon (ANNX) stake by 4.9% in Q2 2026, selling an estimated $182K and leaving 641,029 shares worth $3.66M. The position accounts for 0.37% of the portfolio, ranked #62.

Parkman Healthcare Partners first reported a position in ANNX in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.73M in Q1 2026. 216 funds tracked by Wall St. Rank hold ANNX as of Q2 2026.

Parkman Healthcare Partners held 641,029 shares of Annexon worth $3.66M as of Q2 2026.
Parkman Healthcare Partners sold 32,984 Annexon shares in Q2 2026, an estimated $182K.
Annexon made up 0.37% of Parkman Healthcare Partners's portfolio in Q2 2026, its #62 holding.
Parkman Healthcare Partners first reported a position in Annexon in Q1 2024 and has held it in 10 quarters since.
Parkman Healthcare Partners's Annexon position peaked at $3.73M in Q1 2026.
216 funds tracked by Wall St. Rank held Annexon as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.